98%
921
2 minutes
20
Obesity continues to represent a significant public health concern, with a broad impact from both a health and economic perspective. This analysis assesses the fiscal consequences of overweight and obesity (OAO) in Japan by capturing obesity-attributable lost tax revenue and increased government transfers using a government perspective. The fiscal burden of OAO was estimated using an age-specific prevalence model, which tracked the Japanese population across different body mass index (BMI) categories. The model was populated with fiscal data for Japan, including employment activity and government spending, to calculate tax revenue and transfer costs. A targeted literature review was conducted to identify data estimating the impact of OAO on employment, income, sick leave, retirement, and mortality. These modifiers were applied to Japanese epidemiological and fiscal projections to calculate government tax revenue and spending. The incremental impact of reducing OAO in the general population was subsequently calculated. Results were estimated based on the 2023 Japanese working-age population aged 18 to 70 years. The total fiscal burden of OAO in Japan, defined as BMI of at least 25, is estimated at US 6.3 billion (¥901 billion) and 5.4 billion (¥769 billion), while additional pension payment spending of $0.5 billion (¥77 billion) was estimated, due to higher levels of early retirement. While the health implications of OAO are well documented, this fiscal analysis demonstrates the significant economic burden of OAO both to the healthcare system and broader government accounts. Policies aimed at reducing population-level obesity have the potential to benefit government accounts through increasing employment and reducing public spending, which can offset the cost of implementing these policies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11555824 | PMC |
http://dx.doi.org/10.36469/001c.123991 | DOI Listing |
Int J Infect Dis
September 2025
Division of General Internal Medicine, Jichi Medical University Hospital, Tochigi, Japan; Division of Infectious Diseases, Jichi Medical University Hospital, Tochigi, Japan. Electronic address:
Objectives: To describe trends in the incidences of chronic hepatitis C, hepatocellular carcinoma (HCC), and related healthcare burden after the introduction of interferon-free direct-acting antivirals (DAAs).
Methods: This repeated cross-sectional study (time trend analysis) examined chronic hepatitis C and related healthcare, including HCC, using national claims data covering >98% of healthcare services in Japan between fiscal years 2013 and 2022.
Results: During the study period, 357,877 patients were treated with DAAs.
Appl Health Econ Health Policy
August 2025
Department of Public Health Policy, School of Public Health, University of West Attica, 196 Alexandras Avenue, 115 21, Athens, Greece.
Background: Obesity represents a significant public health and economic problem worldwide. In Greece, where the prevalence of adult obesity is among the highest in Europe, no prior study has examined its economic impact among adults. This study estimates the total economic burden of obesity in Greece for 2024, adopting a societal perspective and considering both direct and indirect costs.
View Article and Find Full Text PDFPublic Health Nutr
August 2025
Centre on Climate Change and Planetary Health, London School of Hygiene and Tropical Medicine, Keppel st, LondonWC1E 7HT, UK.
Objective: To estimate the potential health benefits from the reduction in consumption of salt and sugar following the introduction of a proposed tax on salt and sugar in the United Kingdom (UK).
Design: Epidemiological modelling study. Life-table modelling was used to estimate the expected population health benefits from the reduction in consumption of salt and sugar for four scenarios, each reflecting different manufacturer and consumer responses the proposed tax.
Sci Rep
August 2025
Department of Epidemiology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
Chronic liver disease (CLD) is a major global public health challenge due to its high morbidity and mortality. In Thailand, the burden of CLD remains underexplored despite its significant impact on healthcare systems. This study examines trends in hospitalizations, etiologies, and in-hospital mortality associated with CLD, including cirrhosis and hepatocellular carcinoma (HCC), from 2017 to 2022.
View Article and Find Full Text PDFJ Med Econ
December 2025
Moderna Biopharma Corporation, Toronto, Canada.
Aims: With continued high disease burden in vulnerable groups and fiscal responsibility shifting to Canada's jurisdictions, assessing the economic value of COVID-19 vaccines is critical for optimizing COVID-19 prevention. This study estimated the public health impact and economically justifiable price (EJP) of Moderna's next-generation COVID-19 vaccine (mRNA-1283) versus no vaccination in Canada, and relative to currently authorized vaccines (mRNA-1273; BNT-162b2).
Methods: The target population included individuals aged ≥65 years and 12-64 years at high-risk of severe COVID-19 outcomes, consistent with 2025/2026 national guidelines.